|
|
|
| Clinical Analysis of Transforaminal Lumbar Interbody Fusion for the Treatment of Lumbar Degenerative Disease |
| The Second People’s Hospital of Jingdezhen City，Jingdezhen 333000，China |
|
|
|
|
Abstract Objective：To explore the clinical curative effect of transforaminal lumbar interbody fusion for the treatment of lumbar degenerative disease.Method：The clinical data of 60 patients with lumbar degenerative disease who were treated by transforaminal lumbar interbody fusion in our hospital from January 2011 to May 2013 were retrospectively analyzed. And 65 patients with posterolateral lumbar fusion at the same time were compared and analyzed.Result：（1）The ODI dysfunction index and the VAS scores of waist and leg pain of patients in the two groups postoperative were significantly lower than those of preoperative（P<0.01），and the VAS scores of waist and leg pain of patients in the TLIF group postoperative were significantly lower than those of patients in the PLF group（P<0.05）.（2）The postoperative osseous fusion rate of patients in the TLIF group was 100%，which was obviously higher than 86.15% of patients in the PLF group，the difference was statistically significant（P<0.05）. （3）The lumbar lordosis angle and relative height of intervertebral disc in the two groups postoperative were significantly improved compared with preoperative，and the lumbar lordosis angle and relative intervertebral disc height in the TLIF group were increased obviously compared with the PLF group，the differences were statistically significant（P<0.05）.Conclusion：The transforaminal lumbar interbody fusion and posterolateral lumbar fusion have preferable clinical curative effects for patients with lumbar degenerative diseases，but the extent of the waist and leg pain relief，convergence rate and intervertebral height adjustment of patients by the transforaminal lumbar interbody fusion are superior than those of patients by posterolateral lumbar fusion，so will the transforaminal lumbar interbody fusion can be regarded as a optimizing operation scheme for lumbar degenerative disease.
|
|
|
|
|
|
|
|
|
